332 related articles for article (PubMed ID: 23475683)
41. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.
Bozina N; Bradamante V; Lovrić M
Arh Hig Rada Toksikol; 2009 Jun; 60(2):217-42. PubMed ID: 19581216
[TBL] [Abstract][Full Text] [Related]
42. Advances in molecular modeling of human cytochrome P450 polymorphism.
Martiny VY; Miteva MA
J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621
[TBL] [Abstract][Full Text] [Related]
43. Characterizing the combined effects of cytochrome P450 missense variation within star allele definitions.
Khoza N; Twesigomwe D; Othman H
Pharmacogenomics; 2023 Jul; 24(10):561-578. PubMed ID: 37503750
[No Abstract] [Full Text] [Related]
44. Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies.
Satoh D; Iwado S; Abe S; Kazuki K; Wakuri S; Oshimura M; Kazuki Y
PLoS One; 2017; 12(10):e0187072. PubMed ID: 29065189
[TBL] [Abstract][Full Text] [Related]
45. Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.
Porcelli S; Fabbri C; Spina E; Serretti A; De Ronchi D
Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1101-15. PubMed ID: 21736534
[TBL] [Abstract][Full Text] [Related]
46. The Role of Cytochromes P450 in Infection.
Stavropoulou E; Pircalabioru GG; Bezirtzoglou E
Front Immunol; 2018; 9():89. PubMed ID: 29445375
[TBL] [Abstract][Full Text] [Related]
47. The cytochrome p450 homepage.
Nelson DR
Hum Genomics; 2009 Oct; 4(1):59-65. PubMed ID: 19951895
[TBL] [Abstract][Full Text] [Related]
48. A comprehensive overview of common polymorphic variants that cause missense mutations in human CYPs and UGTs.
Cao X; Durairaj P; Yang F; Bureik M
Biomed Pharmacother; 2019 Mar; 111():983-992. PubMed ID: 30841478
[TBL] [Abstract][Full Text] [Related]
49. Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology.
Nebert DW
Pharmacogenetics; 2000 Jun; 10(4):279-90. PubMed ID: 10862518
[TBL] [Abstract][Full Text] [Related]
50. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.
Nelson DR; Koymans L; Kamataki T; Stegeman JJ; Feyereisen R; Waxman DJ; Waterman MR; Gotoh O; Coon MJ; Estabrook RW; Gunsalus IC; Nebert DW
Pharmacogenetics; 1996 Feb; 6(1):1-42. PubMed ID: 8845856
[TBL] [Abstract][Full Text] [Related]
51. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.
Nelson DR; Kamataki T; Waxman DJ; Guengerich FP; Estabrook RW; Feyereisen R; Gonzalez FJ; Coon MJ; Gunsalus IC; Gotoh O
DNA Cell Biol; 1993; 12(1):1-51. PubMed ID: 7678494
[TBL] [Abstract][Full Text] [Related]
52. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.
Nebert DW; Nelson DR; Coon MJ; Estabrook RW; Feyereisen R; Fujii-Kuriyama Y; Gonzalez FJ; Guengerich FP; Gunsalus IC; Johnson EF
DNA Cell Biol; 1991; 10(1):1-14. PubMed ID: 1991046
[TBL] [Abstract][Full Text] [Related]
53. The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family.
Esteves F; Rueff J; Kranendonk M
J Xenobiot; 2021 Jun; 11(3):94-114. PubMed ID: 34206277
[TBL] [Abstract][Full Text] [Related]
54. Cytochrome P450 enzyme system: genetic polymorphisms and impact on clinical pharmacology.
van der Weide J; Steijns LS
Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():722-9. PubMed ID: 10586308
[TBL] [Abstract][Full Text] [Related]
55. SuperCYPsPred-a web server for the prediction of cytochrome activity.
Banerjee P; Dunkel M; Kemmler E; Preissner R
Nucleic Acids Res; 2020 Jul; 48(W1):W580-W585. PubMed ID: 32182358
[TBL] [Abstract][Full Text] [Related]
56. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.
Nelson DR; Zeldin DC; Hoffman SM; Maltais LJ; Wain HM; Nebert DW
Pharmacogenetics; 2004 Jan; 14(1):1-18. PubMed ID: 15128046
[TBL] [Abstract][Full Text] [Related]
57. Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients.
Parker K; Aasebø W; Haslemo T; Stavem K
Springerplus; 2016; 5():350. PubMed ID: 27066364
[TBL] [Abstract][Full Text] [Related]
58. The impact of CYP allelic variation on antidepressant metabolism: a review.
Black JL; O'Kane DJ; Mrazek DA
Expert Opin Drug Metab Toxicol; 2007 Feb; 3(1):21-31. PubMed ID: 17269892
[TBL] [Abstract][Full Text] [Related]
59. Human CYP allele database: submission criteria procedures and objectives.
Ingelman-Sundberg M; Oscarson M
Methods Enzymol; 2002; 357():28-36. PubMed ID: 12424894
[No Abstract] [Full Text] [Related]
60. Cytochrome P450 genetic polymorphism in neonatal drug metabolism: role and practical consequences towards a new drug culture in neonatology.
Fanni D; Ambu R; Gerosa C; Nemolato S; Castagnola M; Van Eyken P; Faa G; Fanos V
Int J Immunopathol Pharmacol; 2014; 27(1):5-13. PubMed ID: 24674673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
